Trials / Completed
CompletedNCT02649062
Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals
Study of the Pharmacodynamics of NGM282 on Colonic Transit, Bile Acid Homeostasis, and Fecal Fat in Subjects With Functional Constipation and Healthy Individuals
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- NGM Biopharmaceuticals, Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effect of NGM282 on colonic transit, bile acid homeostasis, and fecal fat in subjects with functional constipation and healthy individuals.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | NGM282 | |
| OTHER | Placebo |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-01-01
- Completion
- 2017-01-01
- First posted
- 2016-01-07
- Last updated
- 2018-03-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02649062. Inclusion in this directory is not an endorsement.